K 0 S , Λ, Ξ, Ω and negative particle yields and transverse mass spectra have been measured at central rapidity in Pb-Pb and p-Pb collisions at 158 A GeV/c. Yields are studied as a function of the number of nucleons participating in the collision N part , which is estimated with the Glauber model. From p-Pb to Pb-Pb collisions the particle yields per participant increase substantially. The enhancement is more pronounced for multistrange particles, and exceeds an order of magnitude for the Ω. For a number of participants, N part , greater than 100, however, all yields per participant appear to be constant.
To be published in Physics Letters B
The final oscillation analysis of the complete set of data collected by CHORUS in the years 1994-1997 is presented. Reconstruction algorithms of data extracted by electronic detectors were improved and the data recorded in the emulsion target were analysed by new automated scanning systems, allowing the use of a new method for event reconstruction in emulsion. CHORUS has applied these new techniques to the sample of 1996-1997 events for which no muons were observed in the electronic detectors. Combining the new sample with the data analysed in previous papers, the overall sensitivity of the experiment to the ν τ appearance is thus improved. In a two-neutrino mixing scheme, a 90% C.L. upper limit of sin 2 2θ µτ < 4.4 × 10 −4 is set for large ∆m 2 , improving by a factor 1.5 the previously published CHORUS result.3
Pb interactions are presented as a function of the collision centrality and compared with those obtained from p-Pb collisions. Strangeness enhancement is observed which increases with centrality and with the strangeness content of the hyperon.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.